retatrutide safety retatrutide clinical trial Eli Lilly's shows promising weight loss results in phase 3 Retatrutide for the treatment of

Semaglutide offers a medically proven approach to achieving significant, sustainable weight loss

Incretins and their synthetic mimetics offer benefits by influencing the appetite and satiety centers in the brain, potentially resetting the bodys fat mass and body weight setpoints that are associated with the interplay between orexigenic and anorexigenic signaling pathways

Human clinical trials are strong tools for detecting common side effects and gauging short-to-medium-term safety in the enrolled populations

Its easy to get excited by the potential benefits, but responsible science demands an unflinching look at the risks